Skip to main content
ANGIODYNAMICS INC logo

ANGIODYNAMICS INC — Investor Relations & Filings

Ticker · ANGO ISIN · US03475V1017 LEI · 549300W3VKC5ZKMO8C28 US Manufacturing
Open in API
Filings indexed 1,054 across all filing types
Latest filing 2012-02-10 Major Shareholding Noti…
Country US United States of America
Listing US ANGO

About ANGIODYNAMICS INC

https://www.angiodynamics.com/

AngioDynamics Inc. is a medical technology company focused on developing, manufacturing, and selling innovative, minimally invasive devices. The company's core activities center on restoring healthy blood flow in the vascular system and expanding cancer treatment options. Its product portfolio serves healthcare professionals such as interventional radiologists, cardiologists, and surgeons. Key technology platforms include the Auryon System, an advanced peripheral atherectomy device; the AlphaVac System for mechanical thrombectomy; and the NanoKnife System for precise, non-thermal tumor ablation. AngioDynamics is dedicated to improving patient outcomes through technologies designed for vascular access, peripheral vascular disease, and oncology.

Recent filings

Filing Released Lang Actions
ANGO AS OF 12/31/11
Major Shareholding Notification
2012-02-10 English
PROXY STATEMENT
Proxy Solicitation & Information Statement Classification · 100% confidence The document is identified as a Schedule 14A Proxy Statement filed under the Securities Exchange Act of 1934. It explicitly states it is a Proxy Statement pursuant to Section 14(a) and includes references to solicitation materials under Rule 14a-12. The document length is under 5,000 characters, but the content is consistent with a proxy solicitation document rather than a brief announcement or a report publication notice. There is no indication that this is a report publication announcement or a certification. Therefore, the document fits the category of Proxy Solicitation & Information Statement (PSI).
2012-02-07 English
ANGIODYNAMICS INC 13G AMENDMENT #3
Major Shareholding Notification
2012-02-06 English
FORM 4
Director's Dealing
2012-02-03 English
AMENDMENT NO. 1
Regulatory Filings Classification · 100% confidence The document is a Form 8-A/A Amendment No. 1 filed with the SEC, which is used for registration of certain classes of securities under the Securities Exchange Act of 1934. It amends and supplements a previous Form 8-A related to a Rights Agreement and includes details about a Stock Purchase Agreement and amendments to the Rights Agreement. The document is regulatory in nature, focused on securities registration and amendments to agreements related to stock rights, rather than financial performance, earnings, or management changes. It does not contain financial statements or earnings data, nor is it a report or presentation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory documents that do not fit other specific categories.
2012-02-03 English
CURRENT REPORT
M&A Activity Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The text describes a material definitive agreement for the acquisition of Navilyst by AngioDynamics, including details of the purchase agreement, stockholder approval, financing commitments, and stockholders agreement. It is not a full financial report but an announcement of a significant transaction and related agreements. This fits the category of M&A Activity (TAR) filings, which cover announcements and documents related to merger proposals or takeover bids. The document length is substantial and contains detailed transaction information, not just a brief announcement or a report publication notice. Therefore, the correct classification is TAR with high confidence.
2012-02-03 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.